Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries. / Gerke, Sara; Stern, Ariel; Minssen, Timo.

I: Nature PJ Digital Medicine, Bind 3, 94, 10.07.2020, s. 1-6.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Gerke, S, Stern, A & Minssen, T 2020, 'Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries', Nature PJ Digital Medicine, bind 3, 94, s. 1-6. https://doi.org/10.1038/s41746-020-0306-7

APA

Gerke, S., Stern, A., & Minssen, T. (2020). Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries. Nature PJ Digital Medicine, 3, 1-6. [94]. https://doi.org/10.1038/s41746-020-0306-7

Vancouver

Gerke S, Stern A, Minssen T. Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries. Nature PJ Digital Medicine. 2020 jul. 10;3:1-6. 94. https://doi.org/10.1038/s41746-020-0306-7

Author

Gerke, Sara ; Stern, Ariel ; Minssen, Timo. / Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries. I: Nature PJ Digital Medicine. 2020 ; Bind 3. s. 1-6.

Bibtex

@article{7f82557d8b3f4891a44dcb39b32efcb9,
title = "Germany{\textquoteright}s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries",
abstract = "Reimbursement is a key challenge for many novel digital health solutions. Germany{\textquoteright}s new Digital Healthcare Act (Digitale-Versorgung-Gesetz or DVG) entitles all individuals covered by statutory health insurance to reimbursement for certain digital health applications (i.e., insurers will pay for their use). Since Germany, like the US, is a multi-payer health care system, the new Act provides a particularly interesting case study for US policymakers. We first explain the relevant changes encompassed in the German DVG and provide an overview of the landscape for reimbursement of digital health solutions in the US. We then discuss challenges and unanswered questions raised by the DVG, ranging from the limited scope of the Act to privacy issues. Lastly, we highlight early lessons and opportunities for other countries.",
author = "Sara Gerke and Ariel Stern and Timo Minssen",
year = "2020",
month = jul,
day = "10",
doi = "10.1038/s41746-020-0306-7",
language = "English",
volume = "3",
pages = "1--6",
journal = "Nature PJ Digital Medicine",
issn = "2398-6352",
publisher = "Nature Research",

}

RIS

TY - JOUR

T1 - Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

AU - Gerke, Sara

AU - Stern, Ariel

AU - Minssen, Timo

PY - 2020/7/10

Y1 - 2020/7/10

N2 - Reimbursement is a key challenge for many novel digital health solutions. Germany’s new Digital Healthcare Act (Digitale-Versorgung-Gesetz or DVG) entitles all individuals covered by statutory health insurance to reimbursement for certain digital health applications (i.e., insurers will pay for their use). Since Germany, like the US, is a multi-payer health care system, the new Act provides a particularly interesting case study for US policymakers. We first explain the relevant changes encompassed in the German DVG and provide an overview of the landscape for reimbursement of digital health solutions in the US. We then discuss challenges and unanswered questions raised by the DVG, ranging from the limited scope of the Act to privacy issues. Lastly, we highlight early lessons and opportunities for other countries.

AB - Reimbursement is a key challenge for many novel digital health solutions. Germany’s new Digital Healthcare Act (Digitale-Versorgung-Gesetz or DVG) entitles all individuals covered by statutory health insurance to reimbursement for certain digital health applications (i.e., insurers will pay for their use). Since Germany, like the US, is a multi-payer health care system, the new Act provides a particularly interesting case study for US policymakers. We first explain the relevant changes encompassed in the German DVG and provide an overview of the landscape for reimbursement of digital health solutions in the US. We then discuss challenges and unanswered questions raised by the DVG, ranging from the limited scope of the Act to privacy issues. Lastly, we highlight early lessons and opportunities for other countries.

UR - https://www.nature.com/articles/s41746-020-0306-7

U2 - 10.1038/s41746-020-0306-7

DO - 10.1038/s41746-020-0306-7

M3 - Journal article

C2 - 32685700

VL - 3

SP - 1

EP - 6

JO - Nature PJ Digital Medicine

JF - Nature PJ Digital Medicine

SN - 2398-6352

M1 - 94

ER -

ID: 238631478